Literature DB >> 3298429

Enhanced killing of Candida albicans by murine macrophages treated with macrophage colony-stimulating factor: evidence for augmented expression of mannose receptors.

A Karbassi, J M Becker, J S Foster, R N Moore.   

Abstract

The effect of macrophage colony-stimulating factor (CSF-1) on killing of Candida albicans by murine peritoneal macrophages was determined. The killing capacity of resident peritoneal macrophages was unaffected by CSF-1. However, proteose-peptone-elicited peritoneal exudate macrophages that had been pretreated with CSF-1 (greater than or equal to 1000 U/ml) for 24 or 48 hr exhibited a significantly enhanced capacity to kill C. albicans. CSF-enhanced killing appeared to be independent of endogenously produced interferon-alpha/beta (IFN) in that enhancement by these two agents differed with regard to onset of the effect, target cell responsiveness, and duration of augmented killing. In addition, a highly specific anti-IFN antiserum that totally neutralized IFN augmentation of candidacidal activity had no effect on CSF-induced enhancement. Evidence was obtained indicating that CSF, unlike IFN, augmented mannose-inhibitable binding and ingestion of C. albicans, suggesting that augmented expression of mannose-receptors by CSF-treated macrophages was at least partially responsible for the enhanced killing.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3298429

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Evidence of involvement of the mannose receptor in adhesion of Borrelia burgdorferi to monocyte/macrophages.

Authors:  M Cinco; B Cini; R Murgia; G Presani; M Prodan; S Perticarari
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Anti-bacterial activity of peritoneal cells from transgenic mice producing high levels of GM-CSF.

Authors:  H T Tran; D Metcalf; C Cheers
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

3.  Augmentation of GG2EE macrophage cell line-mediated anti-Candida activity by gamma interferon, tumor necrosis factor, and interleukin-1.

Authors:  E Blasi; S Farinelli; L Varesio; F Bistoni
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

4.  Involvement of mannose receptor in cytokine interleukin-1beta (IL-1beta), IL-6, and granulocyte-macrophage colony-stimulating factor responses, but not in chemokine macrophage inflammatory protein 1beta (MIP-1beta), MIP-2, and KC responses, caused by attachment of Candida albicans to macrophages.

Authors:  Y Yamamoto; T W Klein; H Friedman
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

Review 5.  Macrophages in resistance to candidiasis.

Authors:  A Vázquez-Torres; E Balish
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

6.  Production of granulocyte-macrophage colony-stimulating factor (GM-CSF) by monocytes and large granular lymphocytes stimulated with Mycobacterium avium-M. intracellulare: activation of bactericidal activity by GM-CSF.

Authors:  D K Blanchard; M B Michelini-Norris; C A Pearson; S McMillen; J Y Djeu
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

7.  Extremely rapid endocytosis mediated by the mannose receptor of sinusoidal endothelial rat liver cells.

Authors:  S Magnusson; T Berg
Journal:  Biochem J       Date:  1989-02-01       Impact factor: 3.857

8.  Mechanisms of amphibian macrophage development: characterization of the Xenopus laevis colony-stimulating factor-1 receptor.

Authors:  Leon Grayfer; Eva-Stina Edholm; Jacques Robert
Journal:  Int J Dev Biol       Date:  2014       Impact factor: 2.203

9.  Poly(I.C)-induced interferons enhance susceptibility of SCID mice to systemic candidiasis.

Authors:  J Jensen; A Vazquez-Torres; E Balish
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

10.  Enhancement of susceptibility of CB-17 mice to systemic candidiasis by poly(I . C)-induced interferon.

Authors:  J Jensen; E Balish
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.